Preclinical Assets Market, By Service, By Model type, By End user, By Geography

Description

Preclinical Assets Market is estimated to be valued at USD 6.8 Bn in 2026 and is expected to reach USD 9.2 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 6.8 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.60%	2033 Value Projection:	USD 9.2 Bn

Preclinical assets consist of various types of services such as Bioanalysis and DMPK (Drug Metabolism and pharmacokinetics) studies, which are further sub segmented into in vitro and in vivo analysis, toxicology testing, which are based on GLP and non GLP (Good Laboratory Practices), compound management process R&D (Research and development), custom synthesis, asymmetric synthesis, and others (Scale-up, cGMP (current good manufacturing practices), safety pharmacology). Preclinical assets have two types of models, patient derived organoid (PDO) model and patient derived xenograft model.

Market Dynamics

Increasing number of service launch in preclinical testing by the key market players is expected to drive growth of the global preclinical assets market during the forecast period. For instance, in July 2020, Skinobs, a cosmetic company, announced the launch of a new preclinical testing platform skinobs, an independent tool which provides a 360-degree vision of in vivo efficacy testing. This platform enables users to identify and select the testing methods depending on various criteria such as

Test Category: which include analytical tests, content-contenair interaction, ecotoxicity and biodegradability tests, safety tests, UV (Ultra Violet ) tests, etc.
Claim: which include anti-ageing, anti-pollution, etc.
Test support: which include cell cultures, 3D skin models, etc.

Similarly, in December 2021, Sirona Medical, a software company, announced the launch of its cloud-native radiology operating system (RadOS) optimizing the use of novel AI (Artificial Intelligence) applications in clinical practice at the 2021 Annual Meeting for Radiological Society of North America (RSNA). The platform was based on the combination of technology and artificial intelligence, which would help augment the intelligence of the physician in clinical practices.

Key features of the study:

This report provides an in-depth analysis of the global preclinical assets market, market size (USD Bn), and compound annual growth rate (CAGR (%)) for the forecast period: 2026 - 2033, considering 2025 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global preclinical assets market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Eurofins Scientific, ICON plc, WuXi AppTec, Viroclinics Xplore, Medpace, Inc., Charles River Laboratories., Pharmatest Services, PPD Inc., SGS SA (SGS), Intertek Group plc, Labcorp Drug Development, Laboratory Corporation of America, Inc., Crown Bioscience, Comparative Biosciences, Inc., TCG Lifesciences Private Limited., Shanghai Medicilon Inc., Domainex, Absorption Systems, AmplifyBio, and IQVIA
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global preclinical assets market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preclinical assets market

Market Segmentation

By Service
- Bioanalysis and DMPK studies
- In vitro
- In-vivo
- Toxicology Testing
- GLP
- Non-GLP
- compound management
- Process R&D
- Custom Synthesis
- Asymmetric Synthesis & Others (Scale-up, cGMP, etc.)
- Safety Pharmacology
- Others (Chemistry, etc.)
By Model type
- Patient Derived Organoid (PDO) Model
- Patient derived xenograft model
By End user
- Biopharmaceutical Companies
- Government Institutes
- Others (Academic and Research institutes)
By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Eurofins Scientific
- ICON plc
- WuXi AppTec
- Viroclinics Xplore
- Medpace, Inc.
- Charles River Laboratories.
- Pharmatest Services
- PPD Inc.
- SGS SA (SGS)
- Intertek Group plc
- Labcorp Drug Development
- Laboratory Corporation of America, Inc.
- Crown Bioscience
- Comparative Biosciences, Inc.
- TCG Lifesciences Private Limited.
- Shanghai Medicilon Inc.
- Domainex
- Absorption Systems
- AmplifyBio
- IQVIA

Product Code: CMI5326

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Service
- Market Snapshot, By Model Type
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Technological Advancements
Regulatory Landscape
PEST Analysis

4. Global Preclinical Assets Market, By Service, 2026 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Bioanalysis and DMPK studies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  - In vitro
  - In-vivo
Toxicology Testing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  - GLP
  - Non-GLP
Compound Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  - Process R&D
  - Custom Synthesis
  - Asymmetric Synthesis
  - Others (Scale-up and cGMP)
Safety Pharmacology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others (Chemistry, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Preclinical Assets Market, By Model Type, 2026 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Patient Derived Organoid (PDO) Model
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Patient derived xenograft model
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Preclinical Assets Market, By End User, 2026 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Biopharmaceutical Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Government Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others (Academic and Research institutes)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Preclinical Assets Market, By Region, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Bn)
  - UK
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026-2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Heat Map Analysis
Company Profile
- Eurofins Scientific
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- ICON plc
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- WuXi AppTec
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Viroclinics Xplore
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Medpace, Inc.
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Charles River Laboratories.
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Pharmatest Services
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- PPD Inc.
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- SGS SA (SGS)
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Intertek Group plc
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Labcorp Drug Development
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Laboratory Corporation of America, Inc.
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Crown Bioscience
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Comparative Biosciences, Inc.
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- TCG Lifesciences Private Limited.
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Shanghai Medicilon Inc.
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Domainex
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Absorption Systems
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- AmplifyBio
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- IQVIA
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
Analyst Views

9. Section

References
Research Methodology
About Us